Kangstem Biotech Market Cap

Kangstem Biotech has a market cap or net worth of 375.75 billion as of April 30, 2026. Its market cap has increased by 197.92% in one year.

Market Cap

375.75B

Enterprise Value

346.99B

Revenue

3.57B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,040.00

Market Cap Chart

Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 375.75B, an increase of 190.54%. That is a compound annual growth rate of 10.84%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	379.98B	74.14%
Dec 30, 2025	218.21B	92.71%
Dec 30, 2024	113.23B	-15.48%
Dec 28, 2023	133.97B	21.98%
Dec 29, 2022	109.83B	-11.47%
Dec 30, 2021	124.06B	-36.85%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
IntoCell	603.13B
Kanaph Therapeutics	492.95B
HansBiomed	472.76B
S.Biomedics	426.67B
curacle co.,ltd.	378.57B
Y-Biologics	359.72B
TiumBio	348.94B
NIBEC	314.32B

Market Cap Rankings